These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19917689)

  • 1. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.
    Faust SM; Lu G; Marini BL; Zou W; Gordon D; Iwakura Y; Laouar Y; Bishop DK
    J Immunol; 2009 Dec; 183(11):7297-306. PubMed ID: 19917689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.
    Faust SM; Lu G; Wood SC; Bishop DK
    J Immunol; 2009 Dec; 183(11):7307-13. PubMed ID: 19917705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.
    Booth AJ; Csencsits-Smith K; Wood SC; Lu G; Lipson KE; Bishop DK
    Am J Transplant; 2010 Feb; 10(2):220-30. PubMed ID: 19788504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.
    Diaz JA; Booth AJ; Lu G; Wood SC; Pinsky DJ; Bishop DK
    Am J Transplant; 2009 Aug; 9(8):1773-83. PubMed ID: 19538487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection.
    Csencsits K; Wood SC; Lu G; Faust SM; Brigstock D; Eichwald EJ; Orosz CG; Bishop DK
    Am J Transplant; 2006 May; 6(5 Pt 1):959-66. PubMed ID: 16611331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
    Nathan MJ; Yin D; Eichwald EJ; Bishop DK
    Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 promotes early allograft inflammation.
    Gorbacheva V; Fan R; Li X; Valujskikh A
    Am J Pathol; 2010 Sep; 177(3):1265-73. PubMed ID: 20651239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR signals promote IL-6/IL-17-dependent transplant rejection.
    Chen L; Ahmed E; Wang T; Wang Y; Ochando J; Chong AS; Alegre ML
    J Immunol; 2009 May; 182(10):6217-25. PubMed ID: 19414775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of allograft survival by inhibitory FcγRIIb signaling.
    Callaghan CJ; Win TS; Motallebzadeh R; Conlon TM; Chhabra M; Harper I; Sivaganesh S; Bolton EM; Bradley JA; Brownlie RJ; Smith KG; Pettigrew GJ
    J Immunol; 2012 Dec; 189(12):5694-702. PubMed ID: 23150718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.